Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Jul 2;20(5):e1083–e1120. doi: 10.1016/j.cgh.2021.06.044

Table 5.

Additive interaction between ABCG8 rs4245791 and body mass index in male and female participants

BMI < 25 kg/m2 BMI ≥ 25 kg/m2 Interaction P-value
All participants (HPFS, NHS and NHS II)
rs4245791 Cases/Controls 791/3843 1615/4088
CC ORa (95% CI) 1.0Ref 1.99 (1.88, 2.10)
rs4245791 Cases/Controls 758/3192 1621/3223
TT+TC ORa (95% CI) 1.16 (1.06, 1.26) 2.55 (2.41, 2.68)
Combined Association
Additive interaction: RERI for (95% Cl); H0b: RERI = 0 0.39 (0.18, 0.61) 4.16×10−4
Additive interaction: SI (95% CI); H0b: SI = 1 1.34 (1.16, 1.52) 1.63×10−3
Multiplicative interaction: IOR (95% CI); H0b: IOR = 1 1.10 (0.96, 1.24) 1.71×10−1
Among females (NHS and NHS II)
rs4245791 Cases/Controls 641/3235 1288/3233
CC ORa (95% CI) 1.0Ref 2.10 (1.98, 2.22)
rs4245791 Cases/Controls 626/2678 1333/2509
TT+TC ORa (95% CI) 1.18 (1.07, 1.29) 2.82 (2.66, 2.97)
Combined Association
Additive interaction: RERI for (95% Cl); H0b: RERI = 0 0.53 (0.27, 0.79) 6.05×10−5
Additive interaction: SI (95% CI); H0b: SI = 1 1.41 (1.22, 1.60) 3.62×10−4
Multiplicative interaction: IOR (95% CI); H0b: IOR = 1 1.13 (0.98, 1.29) 1.14×10−1
Among males (HPFS)
rs4245791 Cases/Controls 150/608 327/855
CC ORa (95% CI) 1.0Ref 1.57 (1.30, 1.83)
rs4245791 Cases/Controls 132/514 288/714
TT+TC ORa (95% CI) 1.05 (0.82, 1.27) 1.65 (1.33–1.98)
Combined Association
Additive interaction: RERI for (95% Cl); H0b: RERI = 0 0.04 (−0.36, 0.44) 8.38×10−1
Additive interaction: SI (95% CI); H0b: SI = 1 1.07 (0.41, 1.72) 8.44×10−1
Multiplicative interaction: IOR (95% CI); H0b: IOR = 1 1.01 (0.69, 1.33) 9.55×10−1
a

Odds ratios are unadjusted and conditional on matching factors.

b

H0 = the null hypotheses tests were for RERI = 0; Synergy Index = 1 and interaction odds ratio = 1